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Although all randomised controlled trials (RCT) share
much in common in terms of design, conduct, analysis
and reporting, trials of complex interventions (loosely
“interventions with several interacting components”) can
have special issues which need appropriate consideration
to deliver high quality and credible evidence to change
or inform practice.
For example, blinding the intervention may be impos-
sible (a surgical compared with a medical intervention),
and standardising the intervention (as would be obliga-
tory and easy in a drug trial) difficult to define and
harder still to achieve (for example, reaching a therapeu-
tic alliance between patient and therapist in a cognitive
behavioural therapy RCT). In addition, often complex
intervention trials have patient reported primary out-
comes (for example, quality of life) that present chal-
lenges (e.g. deaths, missing data). Safety reporting in
complex intervention trials often presents particular
challenges, struggling to adapt methodologies designed
and developed for regulatory drug trials.
Designers of complex intervention trials may be forced
to make assumptions about critical features of the inter-
vention (e.g. intensity, and duration) and how to mea-
sure the treatment effect without the funds or the time
to develop these aspects in a similar manner to the
Phase I-IV development of drug trials. Frequently com-
plex intervention trials are underpowered to detect
important effects due to their expense and perceived dif-
ficulties. Often times one is left wondering whether the
failure of a complex intervention trial to detect a treat-
ment effect was down to sub optimal design, rather
than strong & robust evidence that it does not work.
This talk will highlight various methodological chal-
lenges in the various stages of the design and running of
complex intervention trials, including the development
of evidence based interventions and outcomes, through
to interpretation of often difficult analyses and convin-
cing skeptical peers and journals of the robustness of
findings. The talk will be illustrated by practical exam-
ples from many complex intervention trials the speaker
has been involved in, including several large, multicen-
tre, pragmatic trials funded by the NIHR/HTA, and
more explanatory trials funded by MRC/EME. It will
also draw on first-hand experience of sitting as an inde-
pendent statistician / methodologist / trialist on various
Trial Steering Committees and Data Monitoring Boards,
as well as on various funding panels and journals.
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